The latest issue of Humboldt Geographic gathers a decade of maps and stories from Cal Poly Humboldt cartography students, inviting readers to see maps not only as navigational tools but as narrative ...

Not all maps chart the Earth’s surface — and the David Rumsey Map Center’s newest exhibition in Green Library proves just that. The exhibit “Above & Below: Cartography Beyond Terrain” opened on Oct. 8 ...

One of my favorite live wallpaper apps for iPhone is the Live Wallpapers Forever app which brings a healthy selection of live wallpapers that ranges from muted to exuberant. The app is very well ...

Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted cancer treatments haven’t worked for patients ...

Financing led by Pfizer Ventures will support advancement of lead program CBI-1214 into a Phase 1 trial, targeted for enrollment in early 2026, and expand next wave of programs from the ATLAS and ...

This striking study from cartographer and historian Rankin (After the Map) explores the politics of mapmaking. “Maps aren’t just collections of facts,” Rankin writes, but are “profoundly cultural.” ...

Cartography is the discipline of making or studying maps. The process of communicating or visualising spatial data, it is often employed in urban planning, environmental studies, disaster management, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely targets tumors, today announced an ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the ...

Being one of the “wallpaper guys,” my eyes have marveled over some of the best phone wallpapers in existence, and also some of the worst. The thing about finding great wallpapers is that it’s like ...

Gilead Sciences is drawing up $20 million cash to partner with Cartography Biosciences and navigate drug discovery for triple-negative breast cancer and adenocarcinoma, a common form of non-small cell ...